34 products added to the Discount Not Deducted (DND) list from April 2022

Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 34 new products have been added to the list of ‘Drugs for which Discount is Not Deducted’ (DND). From April 2022, the discount deduction scale will no longer apply to prescriptions dispensed for the following products (split into Individual Items and Group Items):

Part II (Drugs for which discount is not deducted (DND)) Additions – Individual Items

  • Aldara 5% cream 250mg sachets
  • Famvir 125mg tablets
  • GlucoRx Aidex Sensor
  • Phosphates enema (Formula B) 128ml standard tube
  • Sancuso 3.1mg/24hours transdermal patches

Part II (Drugs for which discount is not deducted (DND)) Additions – Group Items
(Note: DND status was retrospectively applied to the following Group Items from March 2022)

  • Amiodarone 50mg/5ml oral suspension
  • Azathioprine 50mg/5ml oral solution
  • Chlorothiazide 150mg/5ml oral suspension
  • Chlorothiazide 25mg/5ml oral suspension
  • Co-careldopa 12.5mg/50mg/5ml oral suspension
  • Co-careldopa 25mg/100mg/5ml oral suspension
  • Diazoxide 250mg/5ml oral suspension
  • Diazoxide 50mg/5ml oral suspension
  • Fludrocortisone 100micrograms/5ml oral suspension
  • Gabapentin 100mg/5ml oral solution
  • Gabapentin 100mg/5ml oral suspension
  • Lansoprazole 15mg/5ml oral suspension
  • Lansoprazole 30mg/5ml oral suspension
  • Lansoprazole 5mg/5ml oral suspension
  • Lorazepam 1mg/5ml oral solution
  • Lorazepam 500micrograms/5ml oral solution
  • Losartan 50mg/5ml oral suspension
  • Menadiol 5mg/5ml oral suspension
  • Mercaptamine 0.55% eye drops preservative free
  • Olanzapine 2.5mg/5ml oral suspension
  • Omeprazole 40mg/5ml oral suspension
  • Omeprazole 5mg/5ml oral suspension
  • Phenobarbital 25mg/5ml oral solution
  • Phenobarbital 25mg/5ml oral suspension
  • Quetiapine 25mg/5ml oral suspension
  • Quetiapine 50mg/5ml oral suspension
  • Tetrabenazine 12.5mg/5ml oral suspension
  • Zopiclone 3.75mg/5ml oral suspension
  • Zopiclone 7.5mg/5ml oral suspension

For a list of all the monthly changes to the DND status of products please see the following page Notice of changes to discount not deducted (DND) status of products. A total of 485 products have been granted DND status following checks made by PSNC within the past 20 months.


The DND list is updated monthly by the DHSC and includes grouped and individual items. Individual items are separately listed in Part II of the Drug Tariff. Any items covered by the ‘Group Items’ heading are not listed again individually in Part II. Contractors can also check the Actual Medicinal Product (AMP) listing on Dictionary of Medicines and Devices (dm+d) to identify whether a product meets the DND criteria (see below).

Group items

Any products that are covered by one or more of the Group items categories below are reimbursed without any discount deduction applied.

  • Cold Chain Storage (ALL)
  • Schedule 1, 2 or 3 Controlled Drugs: Products containing drugs listed in Schedules 1, 2 and 3 of the Misuse of Drugs Regulation 2001
  • Cytotoxic or Cytostatic item (ALL):
  • Immunoglobulins (ALL)
  • Insulins for injection (ALL)
  • Vaccines and antisera (ALL)
  • Unlicensed medicines: ‘Specials’ not listed in Part VIIIB where the product has been sourced from a supplier holding a MHRA specials or importers licence (prescriptions must be endorsed with invoice price less discount/rebate)
  • Hazardous chemicals

Individual items  

Products that do not are covered by one or more of the Group item categories above must fulfil all three of the following criteria to qualify for entry to the DND list.

  • the manufacturer(s), AAH and Alliance do not offer pharmacy contractors a discount
  • fewer than 500,000 items per year are dispensed of the product
  • average net ingredient cost (NIC) per item is more than £50

PSNC will continue its work to assess whether other drugs and appliances fulfil the current DND entry requirements under either the ‘Group’ and ‘Individual item’ criteria and make applications to NHSBSA and DHSC, accordingly.

If a product is currently subject to the discount deduction scale and you believe that it should be added to DND list based on the criteria specified above, please contact the PSNC Dispensing and Supply Team by emailing comms.team@cpe.org.uk who will investigate whether the product meets the relevant DND criteria and make an application to the DHSC and NHSBSA, as appropriate.

For further information on how discount deduction works, click here.

Support the call for more funding by recording the informal advice you provide over just one day.

Click Here